Genome-based therapeutics : targeted drug discovery and development : workshop summary /

"The number of new drug approvals has remained reasonably steady for the past 50 years at around 20 to 30 per year, while at the same time the total spending on health-related research and development has tripled since 1990. There are many suspected causes for this trend, including increases in...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Collectivité auteur: Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health
Autres auteurs: Berger, Adam C., Olson, Steve, 1956-
Format: Électronique eBook
Langue:Inglés
Publié: Washington, D.C. : National Academies Press, 2012.
Sujets:
Drugs > United States > Design > Congresses.
Pharmaceutical technology > United States > Congresses.
Pharmaceutical industry > United States > Congresses.
Genomics > United States > Congresses.
Drug Discovery > trends
Genetic Therapy > trends
Médicaments > États-Unis > Conception > Congrès.
Techniques pharmaceutiques > États-Unis > Congrès.
Industrie pharmaceutique > États-Unis > Congrès.
Génomique > États-Unis > Congrès.
MEDICAL > Pharmacology.
Drugs > Design
Genomics
Pharmaceutical industry
Pharmaceutical technology
United States
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Accès en ligne:Texto completo

Internet

Texto completo

Error inesperado del formato de respuesta.
Informations d'exemplaires de

Documents similaires